Hypoloc-Plus (Hydrochlorothiazide, Nebivolol)

Hydrochlorothiazide acts as a thiazide diuretic, blocking sodium‑chloride reabsorption in the kidney, which increases urine output and reduces plasma volume. Nebivolol is a selective β1‑adrenergic blocker that slows heart rate and contractility while enhancing nitric‑oxide release for vasodilation. Together they lower cardiac output and peripheral resistance, resulting in reduced arterial pressure.

The appropriate dose of Hypoloc-Plus is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Hypoloc-Plus in pregnancy or while breastfeeding has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative treatments when appropriate. Women who are pregnant, planning pregnancy, or nursing should discuss options with their physician.

To request Hypoloc-Plus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with single‑agent therapies, Hypoloc-Plus offers a combined thiazide diuretic and beta‑blocker in one tablet, simplifying regimens and potentially improving adherence. It provides both volume reduction and heart‑rate control, which can be advantageous over agents that address only one pathway. Choice of therapy should be individualized based on patient profile and comorbidities.

Hypoloc-Plus should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the tablet container tightly closed and out of reach of children. No refrigeration is required for this oral tablet.

Hypoloc-Plus is taken orally, usually once daily, with or without food, as directed by the prescriber. Swallow the tablet whole with a full glass of water. Do not crush, split, or chew the tablet unless specifically instructed by a healthcare professional.

Serious risks include severe hypotension, significant electrolyte disturbances (such as hyponatremia or hypokalemia), acute kidney injury, and rare allergic reactions like angioedema or anaphylaxis. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling, severe dizziness, or signs of an allergic response.

Hypoloc-Plus is contraindicated in patients with known hypersensitivity to either hydrochlorothiazide or nebivolol, severe renal impairment, or those taking certain interacting medications such as lithium without close monitoring. Individuals with uncontrolled heart failure, severe bradycardia, or certain cardiac conduction disorders should also avoid this combination unless a physician determines it is safe.